These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 23669356)

  • 1. Cell-penetrating peptides: 20 years later, where do we stand?
    Bechara C; Sagan S
    FEBS Lett; 2013 Jun; 587(12):1693-702. PubMed ID: 23669356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of cell-penetrating peptides.
    Johnson RM; Harrison SD; Maclean D
    Methods Mol Biol; 2011; 683():535-51. PubMed ID: 21053155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
    Jobin ML; Alves ID
    Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.
    Freire JM; Veiga AS; Rego de Figueiredo I; de la Torre BG; Santos NC; Andreu D; Da Poian AT; Castanho MA
    FEBS J; 2014 Jan; 281(1):191-215. PubMed ID: 24286593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classes and prediction of cell-penetrating peptides.
    Lindgren M; Langel U
    Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of cell-penetrating peptides as vectors for drug delivery].
    Ren J; Qin CG; Xu CL; Wang QY; Zuo XJ
    Yao Xue Xue Bao; 2010 Jan; 45(1):17-25. PubMed ID: 21351444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling mini cell-penetrating peptides enter by both direct translocation and glycosaminoglycan-dependent endocytosis.
    Bode SA; Thévenin M; Bechara C; Sagan S; Bregant S; Lavielle S; Chassaing G; Burlina F
    Chem Commun (Camb); 2012 Jul; 48(57):7179-81. PubMed ID: 22692031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides: design, synthesis, and applications.
    Copolovici DM; Langel K; Eriste E; Langel Ü
    ACS Nano; 2014 Mar; 8(3):1972-94. PubMed ID: 24559246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the peptide BP100 as a cell-penetrating tool for the chemical engineering of actin filaments within living plant cells.
    Eggenberger K; Mink C; Wadhwani P; Ulrich AS; Nick P
    Chembiochem; 2011 Jan; 12(1):132-7. PubMed ID: 21154994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis.
    Bechara C; Pallerla M; Zaltsman Y; Burlina F; Alves ID; Lequin O; Sagan S
    FASEB J; 2013 Feb; 27(2):738-49. PubMed ID: 23070606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The many futures for cell-penetrating peptides: how soon is now?
    Howl J; Nicholl ID; Jones S
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):767-9. PubMed ID: 17635144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.